|
|
From ACC/AHA Guidelines to Best Practice: Can "Acute MI
Report Cards" Save Lives? Measuring Quality of Care for Patients With
Cardiovascular Disease
Martha J. Radford, MD
Associate Professor of Medicine (Cardiology)
University of Connecticut School of Medicine
Farmington, CT
Quick Overview
Measuring Quality of Care: Pros
and Cons
The Cooperative
Cardiovascular Project
Results of the CCP Pilot
Measuring Quality of Care: Pros
and Cons
The concept of measuring quality of care is one that often makes physicians
uneasy. There is concern that clinical subtleties will not be understood
in measurements designed by nonphysicians. There is concern that making
quantitative estimates of quality of care will lead to inappropriate ranking
of providers based on measures whose precision is not well understood. There
is concern that "cost of care" will be used as a surrogate for
quality of care.
Cardiovascular care is under particular scrutiny. Cardiovascular disease
is common, and care is often "high tech" and expensive. Current
clinical science supports a variety of approaches, and there are limitations
with prescribed patterns of care ("cookbook medicine"). However,
few would deny that it is important to develop quality measures based on
firm scientific evidence that are meaningful to physicians and patients,
likely to lead to improvements in the delivery and outcome of care, which
can inform future clinical research questions and approaches.
The Cooperative
Cardiovascular Project
The Cooperative Cardiovascular Project (CCP) is a landmark medical care
quality improvement initiative in these regards. It is the first project
undertaken by the Health Care Finance Administration (HCFA), which has fiscal
and quality oversight for all care provided to Medicare beneficiaries, according
to principles of quality improvement outlined in 1992. (1)
An important aspect of the CCP is that input from the provider community
was actively sought throughout the project. The Steering Committee consisted
of representatives from all physician groups involved in the care of patients
with coronary artery disease. The American College of Cardiology/American
Heart Association guidelines for the care of patients with acute myocardial
infarction (MI) (2) were used as the basis for designing the quality indicators.
Physicians active in the care of patients were involved in designing the
clinical logic, in verifying whether the logic correctly identified patients
eligible for a given care process, and in analyzing and reporting patterns
of care to physicians, hospitals, and the medical literature.
The CCP Pilot was carried out in four states-Alabama, Connecticut, Iowa,
and Wisconsin-from 1992 through 1994. The principles underlying the CCP
should reassure physicians:
- 1. Clinical information is important for judging quality of care.
Claims data are inadequate for process-of-care inquiries. In Connecticut,
more than 3,000 inpatient records for Medicare patients with acute MI during
1992 and 1993 were reviewed, and more than 750 clinical data elements were
abstracted for each record, including admission history and physical exam,
medications, test results, and complications.
- 2. Recommendations derived from well-designed clinical research (especially
randomized controlled trials) are generalizable. For patients with acute
MI, recommendations pertinent to administration of thrombolytic therapy,
aspirin, beta blockers, ACE inhibitors, and withholding calcium channel
blockers are considered well-grounded in the extensive clinical research.
This research has contributed to the decline in mortality following acute
MI that has been observed over the last two decades.
- 3. For a given intervention, a group of patients "ideal"
to receive that intervention can be identified. This ideal group of patients,
who have clear-cut indications for intervention and no contraindications,
represents an "assay" for process of care. For patients not in
the ideal group, who may have a relative contraindication to or an uncertain
indication for a given care process, decision making is left up to the physician,
with no judgment made about the quality of that decision.
Computerized records for more than 14,000 primary hospitalizations for Medicare
patients with acute MI in Alabama, Connecticut, Iowa, and Wisconsin during
June 1992 through February 1993 make up the CCP Pilot data base. Average
patient age was 75 years, 54% were male, and 30-day mortality was 19%
.
The results of the CCP Pilot have been recently reported,
(3) and show that even for patients considered ideal candidates for a given
intervention, there is evidence of underutilization of accepted therapies
(Table 1).
In addition, there is opportunity for improvement in the time to
administration of thrombolytic therapy. Mean time between hospital arrival
and administration was 1.2 hours; only 11% of patients received thrombolytic
therapy within 30 minutes of arrival, the current national door-to-drug
target.
As important as these insights to providers are, the CCP Pilot has also
demonstrated to the "quality measurers" some important principles:
- 1. Cookbook medicine is not possible. The relatively small size of
the ideal candidate patient set for some therapies surprised many nonphysicians
but did not surprise physicians, who understand how commonly the clinical
characteristics of individual patients modulate care decisions, particularly
for the elderly. For patients who are not ideal candidates, therapy is left
up to physician judgment, as it should be.
- 2. It is easier to analyze patterns of care when the process is recommended
for virtually all patients. Development of the ideal candidate methodology
allowed for analysis of processes of care for generally applicable therapies.
However, within a population-based sample such as the CCP records, quality
of care for exceptional patients, eg, those with septal rupture after acute
MI, cannot be measured in any meaningful way. Care of these far-from-average
patients is an important-and as yet unmeasurable-component of the quality
of care of a medical care system.
The CCP Pilot has demonstrated that some aspects of the quality of medical
care can be measured, and that there is opportunity for improvement in the
delivery of commonly accepted therapies. The CCP is now a national project,
with measurement of quality of care as developed in the Pilot being applied
to hospitals in all 50 states. In fact, the four CCP Pilot states will be
the first to be "assayed" twice. Records from acute MI admissions
in late 1995 in the four pilot states will be examined to see whether there
has been any increase in the utilization of the therapies under examination
and whether improvement in quality of care can be discerned. When this second
inquiry is completed, we will have an answer to the question, can report
cards save lives?
References
1. Jencks SF, Wilensky GR. The health care quality improvement initiative:
a new approach to quality assurance in Medicare. JAMA. 1992;
268:900-903.
2. Gunnar RM, Bourdillon PDV, Dixon DW, et al. Guidelines for the
early management of patients with acute myocardial infarction. J Am Coll
Cardiol. 1990;6:249-292.
3. Ellerbeck EF, Jencks SF, Radford MJ, et al. Quality of care for
Medicare patients with acute myocardial infarction. JAMA. 1995;273:1509-1514.
Return to Index of Articles for Clinician;
Volume 14.4
Home | What's New | What is EHAC? | Abstracts & Articles
Reader's Digest | Contact Us | Search
Tips for Searching
www.ehac.org.
Site by AllSoldOut Internet Solutions
Visit the Clinical Information EHAC site at www.chestpaincenters.org.
Copyright © 1996-2001
by St. Agnes Healthcare. All Rights Reserved.
|
|